| Date Filed | Type | Description |
| 03/29/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/28/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/23/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/23/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t... |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/25/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/10/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/05/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 02/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 11/29/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/25/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/06/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/29/2021 |
GN
| DBV Technologies to Participate in Upcoming Investor Conferences |
| 04/29/2021 |
GN
| DBV Technologies invitée à participer aux prochaines conférences Investisseurs |
| 04/28/2021 |
GN
| Monthly information regarding the total number of voting rights and total number of shares of the Company |
| 04/28/2021 |
GN
| Information mensuelle relative au nombre total des droits de vote et d???actions composant le capital social |
| 04/28/2021 |
GN
| Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic |
| 04/28/2021 |
GN
| L???Assemblée Générale Mixte du 19 mai 2021 se tiendra à huis-clos en raison de la pandémie de COVID-19 |
| 04/02/2021 |
GN
| DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors |
| 04/02/2021 |
GN
| DBV Technologies annonce la nomination de Timothy E. Morris au conseil d'administration |
| 04/01/2021 |
GN
| Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021 |
| 04/01/2021 |
GN
| Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social au 31 mars 2021 |
| 03/26/2021 |
GN
| DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting |
| 03/26/2021 |
GN
| DBV Technologies annonce la nomination d'une nouvelle présidente de son comité d'audit et la date de son assemblée générale annuelle |
| 03/17/2021 |
GN
| DBV Technologies Announces Filing of 2020 Annual Report on Form 10-K and 2020 Universal Registration Document |
| 03/17/2021 |
GN
| DBV Technologies Publie son « Form 10-K » américain et son Document d'Enregistrement Universel 2020 |
| 03/12/2021 |
GN
| Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021 |
| 03/12/2021 |
GN
| Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social au 28 février 2021 |
| 03/11/2021 |
GN
| DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments |
| 03/11/2021 |
GN
| DBV Technologies annonce ses résultats financiers pour l'exercice 2020 et fait le point sur le développement de ses activités |
| 03/05/2021 |
GN
| DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference |
|